Science Explorer Back to mapMap
Discussion
Researcher · Ludwig-Maximilians-Universität München · Germany

Melanie Salvermoser

Melanie Salvermoser publishes mostly in Immunology, Immunology and Allergy and Oncology, on topics such as Cell Adhesion Molecules Research, Neutrophil, Myeloperoxidase and Oxidative Mechanisms and S100 Proteins and Annexins.

OpenAlex
World rank
#1,709,001
of 7,710,434 ranked researchers
Rank in Germany
#84,365
of 364,343
Works
34
Citations
747
Citations per work
22.0
h-index
13
i10-index 14Top 57% in Immunology
Melanie Salvermoser

What does Melanie Salvermoser research?

Melanie Salvermoser's work is mostly in Medicine (35%), Immunology and Microbiology (32%), Biochemistry, Genetics and Molecular Biology (24%).

Life Sciences: 19 works · 55.1% of their workImmunology and Microbiology: 11 works · 31.5% of their workImmunology: 11 works · 31.5% of their workBiochemistry, Genetics and Molecular Biology: 8 works · 23.6% of their workMolecular Biology: 4 works · 12.4% of their workCancer Research: 3 works · 9.0% of their workCell Biology: 1 works · 2.2% of their workHealth Sciences: 12 works · 34.9% of their workMedicine: 12 works · 34.9% of their workImmunology and Allergy: 6 works · 18.0% of their workOncology: 6 works · 16.9% of their workEverything else: 3 works · 10.0% of their workTHEIR WORKMelanieSalvermoser34works
Life Sciences55%Health Sciences35%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Immunology and Microbiology1131.5%
    2. Biochemistry, Genetics and Molecular Biology823.6%
    1. Medicine1234.9%
  3. Everything else310.0%
  1. 1Immunology32% of their works
  2. 2Immunology and Allergy18% of their works
  3. 3Oncology17% of their works
  4. 4Molecular Biology12% of their works
  5. 5Cancer Research9% of their works
  6. 6Cell Biology2% of their works

Research topics

Which keywords describe Melanie Salvermoser's research?

The keywords of their largest research topics: Inflammation, Angiogenesis, Extracellular Matrix, Cell Adhesion, Immunity, Integrins, Metastasis and Innate Immunity.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 23 words, with their numbers
  1. Inflammation424 topics
  2. Angiogenesis222 topics
  3. Extracellular Matrix222 topics
  4. Cell Adhesion161 topic
  5. Immunity162 topics
  6. Integrins161 topic
  7. Metastasis142 topics
  8. Innate Immunity122 topics
  9. Neutrophil Extracellular Traps121 topic
  10. Reactive Oxygen Species121 topic
  11. Cancer Immunotherapy112 topics
  12. Calcium Modulated Proteins81 topic
  13. S100 Proteins81 topic
  14. CAR T Cells71 topic
  15. Chimeric Antigen Receptor71 topic
  16. Immune Checkpoint Blockade71 topic
  17. PD-1 and PD-L171 topic
  18. Matrix Metalloproteinases61 topic
  19. Pattern Recognition Receptors61 topic
  20. Tissue Inhibitors of Metalloproteinases61 topic
  21. Toll-like Receptors61 topic
  22. Antigen Presentation41 topic
  23. Dendritic Cells41 topic

Where does Melanie Salvermoser work?

Melanie Salvermoser's main affiliation in the publication record is Ludwig-Maximilians-Universität München, Germany.

How many publications and citations does Melanie Salvermoser have?

OpenAlex counts 34 works and 747 citations for Melanie Salvermoser, an h-index of 13, ranking #1,709,001 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Melanie Salvermoser. Posts are plain text and can be reported.